IMI Intelligent Medical Implants AG (IMI), a privately held neuro-stimulation company, announced today that it has raised €15 million in a Series B financing led by Global Life Science Ventures (GLSV) and Abingworth Management. Existing investors, including the Series A lead investor PolyTechnos, and a new investor, Quantum Technology Partners, also participated. Stephen J. McCormack of GLSV has become Chairman of IMI and Timothy J. Haines, a Partner at Abingworth, has joined the board.
